TY - JOUR
T1 - Physicians’ practice of discussing fertility preservation with cancer patients and the associated attitudes and barriers
AU - Takeuchi, Emi
AU - Kato, Masashi
AU - Wada, Saho
AU - Yoshida, Saran
AU - Shimizu, Chikako
AU - Miyoshi, Yoko
N1 - Funding Information:
This study was supported by a Health Labour Sciences Research Grant (H26-016) from the Ministry of Health, Labour and Welfare.
Publisher Copyright:
© 2016, Springer-Verlag Berlin Heidelberg.
PY - 2017/4/1
Y1 - 2017/4/1
N2 - Purpose: The aim of this study is to describe physicians’ clinical practice of discussing fertility issues with cancer patients and determine the factors associated with such discussion. Methods: In this cross-sectional study, a nationwide Internet survey was conducted among physicians who provided daily medical care to cancer patients at hospitals or clinics. Participants answered a questionnaire assessing characteristics, discussion practices, attitudes, and barriers regarding fertility preservation. Results: Among the 180 participants, 42% discussed fertility issues with patients daily, and 30% had experience in referring patients to fertility preservation specialists. A multivariate logistic regression analysis showed that those who agreed or strongly agreed with the statements “physicians are responsible for discussing fertility preservation” (OR = 2.04, 95% CI 1.14–3.63, p < 0.05) and “patients who have an exceedingly aggressive disease and need immediate cancer treatment should not be told about fertility issues” (OR =1.84, 95% CI 1.09–3.10, p < 0.05) were nearly twice as likely to discuss fertility issues with patients. Conclusions: Compared to Western countries, fertility issues are less likely to be discussed in Japan. To increase opportunities for patients to discuss fertility issues, the ASCO guidelines should be widely understood. Additionally, these results suggest that physicians who are more likely to discuss fertility issues might feel more conflicted about whether they in fact should discuss such issues with patients with poor prognosis or insufficient time for cancer treatment.
AB - Purpose: The aim of this study is to describe physicians’ clinical practice of discussing fertility issues with cancer patients and determine the factors associated with such discussion. Methods: In this cross-sectional study, a nationwide Internet survey was conducted among physicians who provided daily medical care to cancer patients at hospitals or clinics. Participants answered a questionnaire assessing characteristics, discussion practices, attitudes, and barriers regarding fertility preservation. Results: Among the 180 participants, 42% discussed fertility issues with patients daily, and 30% had experience in referring patients to fertility preservation specialists. A multivariate logistic regression analysis showed that those who agreed or strongly agreed with the statements “physicians are responsible for discussing fertility preservation” (OR = 2.04, 95% CI 1.14–3.63, p < 0.05) and “patients who have an exceedingly aggressive disease and need immediate cancer treatment should not be told about fertility issues” (OR =1.84, 95% CI 1.09–3.10, p < 0.05) were nearly twice as likely to discuss fertility issues with patients. Conclusions: Compared to Western countries, fertility issues are less likely to be discussed in Japan. To increase opportunities for patients to discuss fertility issues, the ASCO guidelines should be widely understood. Additionally, these results suggest that physicians who are more likely to discuss fertility issues might feel more conflicted about whether they in fact should discuss such issues with patients with poor prognosis or insufficient time for cancer treatment.
KW - Attitude
KW - Barrier
KW - Cancer survivor
KW - Discussion
KW - Fertility
UR - http://www.scopus.com/inward/record.url?scp=84997343317&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84997343317&partnerID=8YFLogxK
U2 - 10.1007/s00520-016-3495-5
DO - 10.1007/s00520-016-3495-5
M3 - Article
C2 - 27889828
AN - SCOPUS:84997343317
SN - 0941-4355
VL - 25
SP - 1079
EP - 1085
JO - Supportive Care in Cancer
JF - Supportive Care in Cancer
IS - 4
ER -